Pricing
  1. US-listed companies
  2. EAGLE PHARMACEUTICALS, INC.
  3. Financials
  4. Accounts receivable, net

EAGLE PHARMACEUTICALS, INC.【EGRX】

Market cap
$14.29K
P/E ratio
SummaryFinancials
Period EndAccounts receivable, net (Million USD)YoY (%)
Dec 31, 202272+76.04%
Dec 31, 202141-19.50%
Dec 31, 202051+6.48%
Dec 31, 201948-27.80%
Dec 31, 201866+23.53%
Dec 31, 201754+27.56%
Dec 31, 201642+60.64%
Dec 31, 201526+260.02%
Sep 30, 20147

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)